Company profile: BluePen Biomarkers LLC - integrated biomarker solutions | Zendy

Ian A. Blair | Zendy; Clementina Mesaros | Zendy; Patrick Lilley | Zendy; Matthew Nunez | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Company profile: BluePen Biomarkers LLC - integrated biomarker solutions

Author(s) -

Ian A. Blair,

Clementina Mesaros,

Patrick Lilley,

Matthew Nunez

Publication year - 2016

Publication title -

future science oa

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 0.825

H-Index - 23

ISSN - 2056-5623

DOI - 10.4155/fsoa-2016-0031

Subject(s) - biomarker discovery , biomarker , metabolomics , proteomics , computational biology , omics , genomics , bioinformatics , medicine , biology , biochemistry , genome , gene

BluePen Biomarkers provides a unique comprehensive multi-omics biomarker discovery and validation platform. We can quantify, integrate and analyze genomics, proteomics, metabolomics and lipidomics biomarkers, alongside clinical data, demographics and other phenotypic data. A unique bio-inspired signal processing analytic approach is used that has the proven ability to identify biomarkers in a wide variety of diseases. The resulting biomarkers can be used for diagnosis, prognosis, mechanistic studies and predicting treatment response, in contexts from core research through clinical trials. BluePen Biomarkers provides an additional groundbreaking research goal: identifying surrogate biomarkers from different modalities. This not only provides new biological insights, but enables least invasive, least-cost tests that meet or exceed the predictive quality of current tests.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research